Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Lymphatic vessels develop from various cell types and mechanisms, not just veins.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Adult spiny mice recover better from heart attacks than common lab mice.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

High doses of finasteride cause cell growth and tumors in mice.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Finasteride can cause sexual problems and depression in young men.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Synthetic melanin applied to skin speeds up wound healing.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Polyesters show promise for repairing damaged blood vessels.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Dermatologists are the main innovators in noninvasive cosmetic procedures, with other specialties also contributing significantly.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.